ClinConnect ClinConnect Logo
Search / Trial NCT06712914

Rapid Non-Invasive Brain Stimulation for Hoarding Disorder

Launched by STANFORD UNIVERSITY · Nov 27, 2024

Trial Information

Current as of July 09, 2025

Not yet recruiting

Keywords

Tms Hoarding Disorder Hoarding Clutter I Tbs

ClinConnect Summary

This clinical trial is looking at a new treatment method called rapid non-invasive brain stimulation to see if it can help people with hoarding disorder. Hoarding disorder is a condition where individuals have difficulty parting with possessions, leading to clutter that can interfere with their daily lives. The study aims to determine if this brain stimulation technique can reduce the symptoms of hoarding.

To participate in the trial, you need to be between 18 and 70 years old and have a primary diagnosis of hoarding disorder with noticeable symptoms. It's important that you can understand and agree to the study procedures. However, individuals with certain medical conditions, those who are pregnant or nursing, or those who have had previous brain treatments may not be eligible. If you join the study, you can expect to receive the brain stimulation treatment in a safe and controlled environment, with guidance from the research team. This trial is currently not recruiting participants, but it aims to provide new insights into treatments for hoarding disorder in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age 18-70 years
  • 2. Primary diagnosis of hoarding disorder
  • 3. Sufficient severity of hoarding symptoms
  • 4. Willing and able to understand and complete consent and study procedures
  • Exclusion Criteria:
  • 1. Psychiatric or medical conditions or medications that make participation unsafe
  • 2. Pregnant or nursing females
  • 3. Previous exposure to TMS or ECT
  • 4. History of any implanted device or psychosurgery

About Stanford University

Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.

Locations

Palo Alto, California, United States

Patients applied

0 patients applied

Trial Officials

Carolyn I Rodriguez, MD, PhD

Principal Investigator

Stanford University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported